![[JoVE Video] Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1683236920794-GHP1HR7FC13G07OLIYNZ/JoVE-video-01.png)
Curi Bio Names Nicholas A. Geisse, Ph.D., as New Chief Executive Officer
Read More
Curi Bio is proud to announce that Co-founder and Chief Business Officer Elliot Fisher has been listed as one of Forbes 30 Under 30 in healthcare.
In this 12th annual 30 Under 30 list, Forbes recognizes a set of tomorrow’s brightest young professionals in 20 separate categories, each of which showcase how the leaders are boldly tackling the problems of today.
Read More
Curi Bio Launches Mantarray™ Platform, 3D Engineered Muscle Tissues for Discovery of New Therapeutics
Read More![[Webinar Replay] A Scalable System to Engineer Human 3D Muscle Tissues for Drug Discovery](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1657230079077-3JXIS2LWSMQP6RUCVO2E/Mantarray-Webinar-2022-Curi-Bio_website-01.png)
![[December 2021 Newsletter] Calcium Flux Detection in Engineered Muscle Tissues](https://images.squarespace-cdn.com/content/v1/5ea9dcad38347f7b8405d2f9/1641233693933-YD4C1OG4CB1K0UAPZY46/holiday-2021-01.jpg)